✦ LIBER ✦

A favourable benefit/risk ratio with efalizumab: A review of the clinical evidence

✍ Scribed by Yves Poulin; Kim A. Papp; Wayne Carey; Wayne Gulliver; Aditya K. Gupta

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Benefit-risk ratios in the assessment of

✍ Andrew R. Willan; Bernie J. O'Brien; Deborah J. Cook 📂 Article 📅 1997 🏛 Elsevier Science 🌐 English ⚖ 499 KB

38A Benefit-risk ratios in the assessmen

✍ Andrew R. Willan; Bernie J. O'Brien; Deborah J. Cook 📂 Article 📅 1995 🏛 Elsevier Science 🌐 English ⚖ 62 KB

Clinical benefits and risk analysis of t

✍ Yasuko Tomizawa 📂 Article 📅 2005 🏛 Springer 🌐 English ⚖ 193 KB

The Risks and Benefits of Episiotomy: A

✍ David Banta; Stephen B. Thacker 📂 Article 📅 1982 🏛 John Wiley and Sons 🌐 English ⚖ 551 KB

Optimizing the treatment of atopic derma

✍ U Blume-Peytavi; U Wahn 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 178 KB

Addressing steroid phobia: Improving the

✍ Skoner, Jonathan D.; Schaffner, Timothy J.; Schad, Christine A.; Kwon, Anessa Ye 📂 Article 📅 2008 🏛 OceanSide Publications, Inc 🌐 English ⚖ 444 KB